MDS, Inc. (NY:MDZ)

7.65

+0.08 (1.06%)

MDS, Inc. (NY:MDZ) Delayed :
Previous Close	$7.57	52 Week High	$8.82
Open	$7.33	52 Week Low	$4.42
Day High	$7.69	P/E	N/A
Day Low	$7.28	EPS	$0.00
Volume	281,255
More MDZ Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
DHR	9	MDS	8
VG	2	DHT	2
PAY	2	SEAC	2
SVA	2	HOFT	1
BBI	1	APD	1
HOFT	1	MWE	1

View All Entities

Nov 3, 2009 09:31 AM MDS (MDZ) and Danaher Corp. (DHR) Announce Receipt of Second Request from U.S. FTC for MDS Analytical Tech Sale
Oct 12, 2009 08:36 AM Jefferies & Co Downgrades MDS Inc. (MDZ) to Hold; Valuation Call
Sep 25, 2009 09:41 AM TD Newcrest Downgrades MDS, Inc. (MDZ) to Reduce
Sep 17, 2009 08:08 AM MDS Inc. (MDZ) CEO Plans To Step Down
Sep 10, 2009 07:32 AM MDS Inc. (MDZ) Reports Mixed Q3 Results

Nov 3, 2009 07:00AM MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
Nov 2, 2009 08:00AM MDS Inc. Completes Divestiture of Central Labs Operations
Oct 20, 2009 05:00PM MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies
Oct 9, 2009 11:27AM Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services
Oct 9, 2009 08:00AM MDS Nordion Selected One of Canada's Top 100 Employers for 2010

Sep 6, 2009 08:28 AM Summer Ends with Biotech Buying Spree
Sep 6, 2009 07:48 AM Is There Anything Left at MDS?
Sep 2, 2009 12:45 PM Danaher (DHR) makes acquisition, cuts jobs
Jun 3, 2009 10:33 AM Torstar Vulnerable to Deletion from S&P/TSX - UBS
Jun 2, 2009 11:35 AM Analyst upgrades, downgrades and initiations: CAL, NETL, MAPP, DDUP, LMT ...

observer
on Oct 3, 2008
at 12:33 AM truth The reality is much worse than MDS self claimed. It is oversold, underperformed, poorly managed, low morale.
Article: TD Newcrest Upgrades MDS Inc. (MDZ) to Buy

No comments are currently available.